Palantir is a strong buy with booming AI platforms, 29% revenue growth, and strategic positioning in the AI arms race. Click ...

Alcoa's stock is down ~75% from its ATH. Tariff wars and economic uncertainty added fuel to the fire, but Q1 2025 results ...

CLOs posted positive Q1 total returns as spreads widened and market volatility grew. Amid trade tensions and signs of ...

El Al Israel Airlines soared 45.5% amid regional demand, with 2024 revenues at $3.4B. Explore growth, risks, and the updated ...

MSCI's asset-light business model, high client switching costs, and minimal tariff impact make it a preferred investment ...

Metro has been outperforming the market during these volatile times, and its Q2 results were relatively strong. Find out why ...

At a market cap of 4.7B EUR and EV/EBITDA of 4.8, Arkema is attractively priced, even with a potential 15% EBITDA reduction.

KREF's Series A is attractively priced for a company with a credit rating of B+. Though current yields of near 9% exist, ...

VitalHub, a healthcare software provider, has seen an 18% drop since January 2025 despite a 30% revenue growth during FY2024.

When markets move, we can learn a lot from the outperformers. But we can also learn a lot from the underperformers - and ...

Adriatic Metals PLC upgraded to Buy due to Vareš project ramp-up, expected commercial production in Q1 2025, and favorable ...

Rocket Lab's heavy reliance on government contracts makes it especially vulnerable to cost-cutting in this sector. Check out ...